Stock Report

Download full stock data and analysis for free Last Updated: 05-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Sio Gene Therapies (SIOX) Key Ratios

Stock Card factsheet share-fund-plan-icon

$0.48

up-down-arrow $0.01 (1.70%)

As on 07-Feb-2024 15:59EDT

Market cap

info icon

$35 Mln

Revenue (TTM)

info icon

$0 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

0.8

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- -- -- --
EBIT -46.99 81.85 52.37 14.57 13.44
Net Profit -13.29 86.57 54.49 16.15 13.54
EPS -13.29 86.75 55.78 23.25 14.64
Book Value -- -- -65.15 -38.26 -39.74
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-22Mar-21
EBIT-Margin info ----------
Net Margin info ----------
Return on equity info -78.89-133.01-58.13-78.26-35.07
Return on Capital info -63.39-90.56---76.69-32.02
Return on Assets info -54.62-74.10-35.68-68.39-28.34
Debt to Equity (x) info ----0.000.040.01

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
Sio Gene Therapies (SIOX)
--
--
-76.69
-32.02
-81.45
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

--

--

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
Sio Gene Therapies (SIOX)
--
-58.13
-78.26
-35.07
-123.34
Peer Median
18.97
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

--

--

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
Sio Gene Therapies (SIOX)
--
-35.68
-68.39
-28.34
-67.13
Peer Median
2.86
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

EBIT Growth

--

--

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
Sio Gene Therapies (SIOX)
--
52.37
-110.67
49.41
45.25
Peer Median
8.26
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

--

--

Year on year growth in profit after tax

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
Sio Gene Therapies (SIOX)
--
54.49
-121.70
55.35
43.73
Peer Median
7.73
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

--

--

Year on year growth in earnings per share

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
Sio Gene Therapies (SIOX)
--
55.78
-0.58
0.79
0.64
Peer Median
10.39
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
Sio Gene Therapies (SIOX)
--
-41.64
--
--
--
Peer Median
4.87
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
Sio Gene Therapies (SIOX)
--
--
0.04
0.01
0.27
Peer Median
0.59
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
Sio Gene Therapies (SIOX)
--
--
0.01
0.00
0.26
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

--

--

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
Sio Gene Therapies (SIOX)
--
21.97
5.52
12.20
2.67
Peer Median
1.65
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

--

--

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
Sio Gene Therapies (SIOX)
--
21.97
--
12.75
2.72
Peer Median
1.20
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

--

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
Sio Gene Therapies (SIOX)
--
-34.86
-2,676.56
-42.93
-15.49
Peer Median
4.77
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Asset Turnover

--

--

Sales / Average Total Assets

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
Sio Gene Therapies (SIOX)
--
--
--
--
--
Peer Median
0.40
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
Sio Gene Therapies (SIOX)
--
--
--
-1,761.34
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
Sio Gene Therapies (SIOX)
--
--
--
1,314.95
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
Sio Gene Therapies (SIOX)
--
--
-0.68
-4.19
-0.84
Peer Median
37.32
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

--

--

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
Sio Gene Therapies (SIOX)
--
0.78
0.81
1.10
0.99
Peer Median
7.75
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
Sio Gene Therapies (SIOX)
--
--
--
--
--
Peer Median
0.50
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

--

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
Sio Gene Therapies (SIOX)
--
0.37
0.17
-0.43
0.14
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

--

--

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-22
Mar-21
Mar-20
Mar-19
Sio Gene Therapies (SIOX)
--
35
--
--
--
Peer Median
2,521
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...